Prospective Observational Study of Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

Type of Study:

Observational

Study Design:

Observational Model: Defined Population, Observational Model: Natural History, Time Perspective: Longitudinal, Time Perspective: Prospective

Principal Investigator

Medical Monitor

Investigator Role:

Study Director

Investigator Affiliation:

Wyeth is now a wholly owned subsidiary of Pfizer

Authority:

United States: Institutional Review Board

Study ID:

0903X-100847

NCT ID:

NCT00161668

Start Date:

October 2001

Completion Date:

Related Keywords:

• Acute Myeloid Leukemia
• Leukemia
• Leukemia
• Leukemia, Myeloid, Acute
• Leukemia, Myeloid

Name	Location
	Hinsdale, Illinois  60521
	Bettendorf, Iowa  52722
	Phoenix, Arizona  85012
	Fountain Valley, California  92708
	Miami, Florida  33176
	Columbia, Missouri  65203
	Albany, New York  12208
	Cleveland, Ohio  44195
	Philadelphia, Pennsylvania  19104
	Nashville, Tennessee  37203-1632
	Austin, Texas  78705
	Flint, Michigan  48532
	Louisville, Kentucky  40207
	McLean, Virginia  22101
	Hackensack, New Jersey  07601
	Albuquerque, New Mexico  87131-5636
	Metairie, Louisiana  70006
	Denver, Colorado
	Charlotte, North Carolina
	Eugene, Oregon
	Milwaukee, Wisconsin
	Indianapolis, Indiana
	Tulsa, Oklahoma
	Charleston, West Virginia  25304
	Bismarck, North Dakota  58501